Personalized Medicine

Octave Bioscience Secures $14 Million Series A Financing Round

July 12, 2018

–George Scangos, PhD, and Michael Pellini, MD, Join Board of Directors, Bring Expertise in Chronic Neurodegenerative Markets and Molecular Insights for Improved Care– Menlo Park, CA, July 12 — Octave Bioscience, the developer of a fully integrated care management solution delivering powerful insights for patients with neurodegenerative diseases, today announced the completion of its Series […]

Integreview IRB Adds Renowned Professor Emeritus to Team

July 11, 2018

IntegReview IRB announces that Ernest D. Prentice, Ph.D., has joined the organization as a Senior Consultant to the IRB. In his new role, Dr. Prentice will work with IntegReview leadership to provide consultation to the IRB and educate researchers by speaking at upcoming research conferences. “We are thrilled to work with someone as experienced and […]

Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer

June 24, 2018

Maternal fetal medicine expert joins Sera to improve pregnancy health globally SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., a women’s healthcare company, announced today that Garrett K. Lam, M.D., FACOG, will be joining the company as chief medical officer on September 4, 2018. Dr. Lam will direct all clinical development […]

TEDMED 2018

June 19, 2018

TEDMED is the health and medicine edition of the famous TED conference. Once a year, a select group of Delegates come together for 2 ½ days to experience 40+ remarkable speakers and 20 disruptive innovators as they transport all of us into a new world of possibilities for our health.

New study launched to identify women at high risk of preterm birth, most effective interventions

June 6, 2018

Researchers are launching the first study of its kind involving up to 10,000 women that will use a new test to identify those at risk for premature birth, and, in those with high risk, to evaluate the impact of early interventions designed to prolong their pregnancy and reduce the rate of premature delivery. For the […]

Valisure is Launching the First Digital Pharmacy to Chemically Validate Medications

May 7, 2018

VALISURE IS LAUNCHING THE FIRST DIGITAL PHARMACY TO CHEMICALLY VALIDATE MEDICATIONS Valisure will deliver medications to consumers that have been batch-tested and validated for quality and consistency LAS VEGAS, NV – MAY 7, 2018 – Valisure is launching the first digital pharmacy to dispense chemically validated medications direct to consumers this Summer 2018, as announced […]

Almac Diagnostics Validates Illumina TruSight® Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials

April 18, 2018

Almac Diagnostics, a global stratified medicine company specialising in biomarker driven clinical trials, has analytically validated Illumina’s TruSight® Tumor 170 cancer mutation panel as an IUO assay for prospective testing in clinical trials. Almac Diagnostics is now in a position to partner with interested Pharmaceutical and Biotech firms with the Almac clinical trial assay to […]

ActiGraph Collaborates with Bayer in Mobile App Usability Pilot Study

April 11, 2018

Pensacola, FL (April 12, 2018) – ActiGraph, a leading provider of medical-grade wearable activity and sleep monitoring solutions, is collaborating with Bayer in an ongoing pilot study evaluating usability and patient perceptions of a digital tool suite consisting of Clinical Ink’s SureSource Engage mobile application, an ActiGraph activity monitor, and a Bluetooth-enabled weight scale. The […]

FEEDBACK